Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Organic silicium refers to bioavailable forms of silicon used primarily as dietary supplements or in topical/mesotherapy formulations. It is most commonly found as orthosilicic acid or monomethylsilanetriol (MMST), which are more readily absorbed by the human body compared to inorganic forms. Organic silicium is promoted for its role in collagen synthesis and connective tissue health and is claimed to support bone strength and skin elasticity. It has been used orally as a supplement and via injection (notably in aesthetic medicine) for conditions such as skin aging and cellulite. The mechanism of action involves supporting collagen formation and possibly modulating inflammation; however, robust clinical evidence for these uses remains limited[3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on organic silicium.